Clinical Trial Update: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing gamma-aminobutyric acid (GABA) function in psychosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder with Psychotic Features
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: University of Michigan | Conditions: Schizophrenia, Bipolar Disorder | Phase 4 | Status: COMPLETED